Sponsors (3)
The bill boosts U.S. ability to deter and punish foreign chemical/biological misuse through faster, clearer sanctions and export/procurement restrictions, but that increased leverage comes with meaningful economic costs, administrative burdens, diplomatic risks, and the potential for rapid sanctions against individuals with limited process protections.
Taxpayers and the U.S. government can more quickly and consistently impose targeted sanctions, suspend research cooperation, cut key exports, and ban certain procurements to deter and disrupt foreign chemical/biological misuse.
Federal agencies, Congress, and policymakers get clearer, more fact-based and consistent decisionmaking and oversight because the statute clarifies language, requires weighing evidentiary and treaty factors, and standardizes reporting—reducing litigation risk and administrative uncertainty.
Congress and policymakers receive clearer, more specific reports when an individual official is implicated, improving transparency and accountability for executive determinations.
U.S. exporters, small businesses, government contractors, financial institutions, and taxpayers could face lost sales, supply‑chain disruptions, higher procurement costs, and substantial compliance burdens from broad export prohibitions, purchase bans, and licensing blocks.
Terminating or cutting most foreign assistance and quicker sanctioning risks undermining long‑term U.S. diplomatic leverage and cooperation, could provoke retaliatory measures, and impair broader security and policy partnerships.
Hospitals, universities, and civilian researchers could see international scientific collaboration and civilian programs constrained by broad export and licensing controls, harming research, medical care, and education.
Based on analysis of 5 sections of legislative text.
Adds an individual-focused determination process and requires mandatory sanctions (suspend scientific cooperation, block certain exports, restrict procurement and assistance) when a foreign official commits a covered chemical/biological act.
Introduced January 9, 2025 by James E. Banks · Last progress January 9, 2025
Creates a new, faster process for the President to act when credible information indicates a foreign government official, employee, or agent committed a covered chemical or biological act. The President must decide within 60 days whether the individual committed the act and, if so, impose immediate mandatory sanctions on the country most closely associated with the entity and follow specific reporting timelines. Requires three mandatory sanctions within 30 days (suspend U.S. scientific cooperation with that country, block certain Commerce Control List Category 1 and 2 exports/reexports/transfers, and prohibit U.S. procurement from persons operating in that country’s chemical/biological sectors). Within 120 days the President must report whether the country addressed the act and cooperated; if the country failed to respond or take remedial steps, the President must impose at least two additional specified sanctions (examples include terminating most foreign assistance and broader export controls). The bill also reorganizes and clarifies language in the existing Chemical and Biological Weapons Control and Warfare Elimination Act and makes a technical cross-reference change.